Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
USP9Y pseudogene 31 (USP9YP31) is a pseudogene located on chromosome Y (Yp11.2), described as a sequence similar to that encoding ubiquitin specific peptidase 9, Y-linked (USP9Y), but it does not produce a functional protein product[1][4]. Pseudogenes typically arise from duplication or retrotransposition of functional genes but accumulate mutations that prevent their translation into functional proteins. There is no evidence for a biological function, disease association, or status as a therapeutic target for USP9YP31. Its categorization as a pseudogene and the lack of protein-coding potential preclude it from being a valid molecular target for therapy or diagnostics[1][4]. USP9YP31 should not be confused with the functional USP9Y gene (ubiquitin specific peptidase 9, Y-linked), which encodes a deubiquitinating enzyme with roles in spermatogenesis and can be associated with male infertility[3][6]. The entry USP9YP31 is specifically a noncoding pseudogene, not a protein-coding gene[1][4][5]. There is no evidence for pharmacological interactions, biomarker status, or involvement in clinical conditions for USP9YP31. This target is not therapeutically relevant, is a non-functional pseudogene, and should be flagged as "incorrect" for use as a drug target or biomarker[1][4]. It is possible you are seeking information on the canonical gene USP9Y (not USP9YP31), which is a separate entity and is associated with cellular functions and disease states[3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on USP9Y pseudogene 31 (USP9YP31).